Anavex Life Sciences
AVXL
184 hedge funds and large institutions have $136M invested in Anavex Life Sciences in 2025 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 28 closing their positions.
36% more call options, than puts
Call options by funds: $9.68M | Put options by funds: $7.13M
11% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 54
4.12% more ownership
Funds ownership: 38.21% → 42.33% (+4.1%)
4% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 28
1% less funds holding
Funds holding: 186 → 184 (-2)
55% less capital invested
Capital invested by funds: $300M → $136M (-$165M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.72M |
| 2 |
Two Sigma Investments
New York
|
+$3.78M |
| 3 |
Goldman Sachs
New York
|
+$3.49M |
| 4 |
Jane Street
New York
|
+$3.37M |
| 5 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$1.85M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$1.58M |
| 4 |
OE
October Effect
Virginia Beach,
Virginia
|
-$1.22M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.01M |
AVXL Hedge Fund Activity: Q4 2025 in Review
184 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2025, worth a combined $136M — down 55% from $300M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new AVXL positions and 28 closed out — a net gain of 1 holder — while 60 added to existing stakes and 54 trimmed.
The largest buyer was State Street, adding an estimated $6.72M. The largest seller was Pier Capital, exiting entirely with an estimated $3.7M sold.
- 184 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2025, down from 186 in Q3 2025.
- Funds reported $136M of Anavex Life Sciences stock for Q4 2025, down 55% quarter-over-quarter.
- 29 funds opened new Anavex Life Sciences positions in Q4 2025 and 28 closed out, a net change of +1 holder.
- The largest Anavex Life Sciences buyer in Q4 2025 was State Street, an estimated $6.72M added.
- The largest Anavex Life Sciences seller in Q4 2025 was Pier Capital, an estimated $3.7M sold.
Based on aggregated 13F filings for Q4 2025.